Reading ADTN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ADTN free→Reading ADTN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ADTN free→QuarterlyIQ Insights · ADTN
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 5 valuation methods, at three horizons. Current price $15.26. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer EV/EBITDA | 12M | $13.80 | 24.2 | 0.64 | TTM | low |
| Peer P/FCF | 12M | $17.54 | 24.2 | 0.73 | TTM | low |
| Peer P/E | 12M | $4.36 | 39.6 | 0.11 | TTM | low |
| Peer P/S | 12M | $46.20 | 3.5 | 13.30 | TTM | low |
| triangulated | 12M |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
| $4.11 |
| 39.6 |
| 0.10 |
| Triangulated |
| low |
| Peer P/S | 3Y | $66.73 | 3.5 | 19.21 | Analyst | medium |
| Peer P/S | 5Y | $85.27 | 3.5 | 24.54 | Analyst | medium |